10/4/24 16:05 | 10/3/24 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Okazaki Jason A | CA | DO | CEO,P | S | -3 | 14.81 | 0 | 0 | -1 | 15 | D | | | | | | | | | | | | | | |
8/5/24 16:05 | 8/2/24 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Okazaki Jason A | CA | DO | CEO,P | S | -14 | 14.23 | 0 | -1 | -6 | 15 | D | | | | | | | | | | | | | | |
5/24/24 16:05 | 5/23/24 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Okazaki Jason A | CA | DO | CEO,P | S | -8 | 14.93 | 0 | -1 | -3 | 16 | D | | | | | | | | | | | | | | |
5/1/24 16:05 | 4/30/24 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Okazaki Jason A | CA | DO | CEO,P | S | -20 | 12.71 | 0 | -2 | -9 | 16 | D | | | | | | | | | | | | | | |
4/2/24 16:05 | 4/1/24 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Okazaki Jason A | CA | DO | CEO,P | S.d | -5 | 13.07 | 0 | 0 | -2 | 14 | D | | | | | | | | | | | | | | |
3/29/24 16:05 | 3/27/24 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Okazaki Jason A | CA | DO | CEO,P | S | -5 | 12.87 | 0 | 0 | -3 | 14 | D | | | | | | | | | | | | | | |
10/4/23 16:05 | 10/3/23 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Okazaki Jason A | CA | DO | CEO,P | S | -2 | 0.7953 | 0 | -2 | -1 | 175 | D | | | | | | | | | | | | | | |
8/3/23 16:05 | 8/2/23 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Okazaki Jason A | CA | DO | CEO,P | S | -13 | 1.09 | 0 | -12 | -7 | 165 | D | | | | | | | | | | | | | | |
5/24/23 17:00 | 5/23/23 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Okazaki Jason A | CA | DO | CEO,P | S | -7 | 1.04 | 0 | -7 | -5 | 127 | D | | | | | | | | | | | | | | |
3/31/23 16:30 | 3/30/23 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Okazaki Jason A | CA | DO | CEO,P | S.d | -3 | 0.8232 | 0 | -4 | -4 | 98 | D | | | | | | | | | | | | | | |
3/28/23 16:05 | 3/27/23 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Okazaki Jason A | CA | DO | CEO,P | S | -5 | 1.02 | 0 | -5 | -4 | 102 | D | | | | | | | | | | | | | | |
3/31/22 16:41 | 3/30/22 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Okazaki Jason A | CA | O | COO | S.d | -3 | 2.17 | 0 | -1 | -1 | 95 | D | | | | | | | | | | | | | | |
3/29/22 19:33 | 3/28/22 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Okazaki Jason A | CA | O | COO | S | -10 | 2.24 | 0 | -5 | -7 | 65 | D | | | | | | | | | | | | | | |